Inflammatory Cytokine Profile in Pregnant Women Colonized With Group B Streptococcus Reveals IL-17a as a Potential Biomarker to Identify at-risk Newborns
Authors:
- 11 February 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (5) , 888-898
Abstract
Background: Group B Streptococcus (GBS) is a commensal vaginal bacterium that can lead to adverse maternal and neonatal outcomes. In low or middle-income countries, few data are available regarding the immune-inflammatory response in GBS-colonized pregnant mothers and its association with the risk of neonatal invasive disease. In this investigation, we implement a prospective study on a cohort of mother–newborn dyads in Morocco to assess the cytokine profile in GBS-colonized-mothers whose newborns have invasive GBS disease. Methods: Pregnant women between 35 and 40 weeks of gestation were screened for vaginal colonization by GBS and followed up until delivery. A panel of inflammatory cytokines was quantified by Luminex multiplex assays and by ELISA in maternal and cord blood, as well as in supernatants after stimulation of pathogen recognition receptors. GBS-colonized-mothers were clustered according to clinical and inflammation markers and to their newborn's infection status. Results: GBS-colonized-mothers whose newborns developed invasive GBS disease exhibited significantly lower IL-1β, IL-4, and IL-17A production compared with GBS-colonized-mothers with healthy newborns. Similar results were obtained following ex vivo stimulation of peripheral blood cells by TLR4 and TLR1/2 ligands. The level of circulating maternal IL-17A had a higher significant predictive value for GBS transmission leading to invasive neonatal disease. Conclusions: This study shows that GBS-colonized-mothers may exhibit a greater cytokine inflammatory response compared with noncolonized-mothers. Regarding mother–newborn dyads, maternal IL-17A, a key mediator of antibacterial defense, emerges as a significant prognostic biomarker for assessing the risk of GBS transmission and the development of neonatal GBS invasive disease.Keywords
Funding Information
- Académie de recherche et d'enseignement supérieur
This publication has 21 references indexed in Scilit:
- Sex difference in innate inflammatory response and macrophage polarization in Streptococcus agalactiae-induced pneumonia and potential role of microRNA-223-3pScientific Reports, 2022
- Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burdenThe Lancet Global Health, 2022
- Identification of progranulin as a novel diagnostic biomarker for early-onset sepsis in neonatesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- The Double Life of Group B Streptococcus: Asymptomatic Colonizer and Potent PathogenJournal of Molecular Biology, 2019
- Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohortVaccine, 2017
- Activation of the IL-1β/CXCL1/MMP-10 axis in chorioamnionitis induced by inactivated Group B StreptococcusPlacenta, 2016
- Characterization of host immunity during persistent vaginal colonization by Group B StreptococcusMucosal Immunology, 2015
- Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2014
- Induction, function and regulation of IL‐17‐producing T cellsEuropean Journal of Immunology, 2008
- Infection néonatale à streptocoque du groupe B à Casablanca (Maroc)Medecine Et Maladies Infectieuses, 1998